NTRA - CIK 0001604821
Natera, Inc. trades as NTRA and has a market capitalization of $31.01 B, making it the #451 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $2.31B, up 35.9% from the prior year and net income of -$208.16M. This page tracks Natera, Inc. through 1,695 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Natera, Inc.'s revenue grew from $217.07M to $2.31B, a compound annual growth rate of 30.0%. Net profit margin expanded from -46.2% to -9.0% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-08 |
| Major company event | 8-K | 2026-05-07 |
| Insider trade | 4 | 2026-05-06 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
| Insider trade | 4 | 2026-05-05 |
Natera Reports First Quarter 2026 Financial Results
Natera Reports Fourth Quarter and Full Year 2025 Financial Results
Natera to Report its Fourth Quarter and Full Year Results on February 26, 2026 ; Event: Natera's Fourth Quarter & Full Year 2025 Financial ...
The largest companies sharing Natera, Inc.'s SEC industry classification (services-medical laboratories).
Natera, Inc. (NTRA) has a market capitalization of $31.01 B as of 2026-06-10, ranking #451 among US-listed companies.
Natera, Inc. reported revenue of $2.31B for fiscal year 2025, an increase of 35.9% year over year.
In its latest fiscal year Natera, Inc. reported a net loss of $208.16M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.